Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 11,000 shares at $10.80 ($119K) on 2023-07-06, disclosed to the SEC on 2023-07-10.
Scheduled sale ($119k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.80 | 5,500 | $59K | 50.0% |
| 2 | $10.80 | 5,500 | $59K | 50.0% |
| Total | $10.80 avg | 11,000 | $119K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-11 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $24K | — | Filing → |